Likewise, the targeting of Notch ligands looked quite appealing, since JAG1 knockdown sensitized ovarian cancer cells to docetaxel and it disrupted tumor angiogenesis in vivo at least in part by affecting the crosstalk with GLI2 [461]. The gene discussed is JAG1; the disease is ovarian cancer.